Author archives: Kathy Neuzil

Kathy NeuzilKathy Neuzil, MD, MPH, directs PATH’s activities in vaccine access and delivery. Dr. Neuzil has provided strategic leadership, direction, and technical guidance for a variety of vaccine projects and studies, including work on vaccines against rotavirus, HPV, Japanese encephalitis, and influenza. Before joining PATH, Dr. Neuzil held academic positions at the University of Washington and Vanderbilt University, where she led research projects on viral and bacterial vaccines including influenza, respiratory syncytial virus, pneumococcus, and varicella-zoster virus. She holds a clinical professorship in medicine and global health at the University of Washington and has contributed more than 100 scientific papers on vaccines and infectious diseases.

Saving lives through essential vaccines: reimagining “routine” immunization

Look up the word routine, and you’ll find the synonyms “humdrum,” “monotonous,” and “dull.” Routine immunization is anything but monotonous—it saves millions of lives, prevents disability, and is continuously monitored and re-evaluated as new information becomes available. Perhaps it’s time … Continue reading »